-+ 0.00%
-+ 0.00%
-+ 0.00%

TME Pharma provides update on its activities

Barchart·08/24/2026 01:05:00
Listen to the news

TME Pharma provides update on its activities

Berlin, Germany, August 24, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for brain cancer and eye diseases, today provides an update on its activities, including the strategic development options for its lead oncology asset, NOX-A12.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.